Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Synaptonemal complex protein 1 (SYCP1) is a core structural component of the synaptonemal complex, a supramolecular protein scaffold that forms between pairs of homologous chromosomes during meiosis in germ cells[2][3]. SYCP1 self-assembles into transverse filaments, forming a zipper-like lattice that stabilizes chromosome pairing and enables genetic recombination and accurate chromosome segregation[3]. SYCP1 consists of long α-helical coiled-coil domains, oligomerizing into an obligate tetrameric structure with N-terminal and C-terminal assembly sites[2][3]. It is essential for fertility, with mutations or dysfunction leading to meiotic failure and infertility. SYCP1 is also classified as a cancer/testis antigen and is occasionally used as a biomarker in certain cancers[2]. There are currently no drugs known to directly target SYCP1, nor is it considered a therapeutic target in the classic sense (such as a receptor or enzyme)[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Synaptonemal complex protein 1 (SYCP1).